A Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing a Full Spectrum Optical Technology
FUSE
Single-Center, Exploratory Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing EndoChoice's Full Spectrum Optical Technology
1 other identifier
interventional
30
1 country
1
Brief Summary
EndoChoice's FUSE System enables a wider view range via 1-2 additional cameras (depending on the model). These optical properties are to be examined and reviewed in this trial (mainly usability and safety)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 5, 2014
CompletedFirst Posted
Study publicly available on registry
May 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedNovember 3, 2016
November 1, 2016
8 months
May 5, 2014
November 2, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Performance, usability and ease of use
The performance of the device is assessed via a performance questionnaire which the recruiting (and treatment providing) physician will answer.
1 Year
Secondary Outcomes (1)
Safety
1 Year
Study Arms (1)
Endoscopy exploratory single arm
EXPERIMENTALExploratory single arm, the system will be used in otherwise standard procedures, and will be reviewed in terms of performance, usability, ease of use and safety.
Interventions
The investigational device will be applied in otherwise standard procedures (upper and lower Gastrointestinal tract endoscopy)
Eligibility Criteria
You may qualify if:
- Male and Female patients ages of 18-70
- The patient has been scheduled for routine screening upper or lower endoscopy, diagnostic endoscopic work up, or endoscopic surveillance.
- Signed informed consent
You may not qualify if:
- Patients with inflammatory bowel disease;
- Patients with a personal history of polyposis syndrome;
- Patients with suspected bowel stricture potentially precluding complete endoscopy
- Patients with a history of diverticulitis or toxic megacolon
- Patients with a history of radiation therapy to neck, abdomen, pelvis;
- Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
- Patients with GI bleeding, that has not been corrected prior to endoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam medical center
Haifa, Israel, 31096, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ian Gralnek, Prof.
Rambam Medical Center Gastroenterological institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2014
First Posted
May 21, 2014
Study Start
May 1, 2014
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
November 3, 2016
Record last verified: 2016-11